Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Pharm Research Associates (UK) Ltd withdraws marketing authorisation application for Surfaxin 8 Ιούνιος 2006Press release European Medicines Agency adopts a positive opinion for the use of Prozac in the treatment of children and adolescents suffering from depression 6 Ιούνιος 2006Press releaseHumanMedicinesPaediatrics European Medicines Agency: Committee for Medicinal Products for Human Use 24-27 May 2006 2 Ιούνιος 2006Press releaseHumanMedicines European Medicines Agency adopts first positive opinion for a medicinal product derived from transgenic biotechnology 2 Ιούνιος 2006Press releaseMedicines European quality leader of the year 2006 award goes to EMEA staff member 2 Ιούνιος 2006Press release European Union (European Commission and European Medicines Agency (EMEA)) and Food and Drug Administration (FDA) agree on guiding principles for joint FDA-EMEA voluntary genomic data submission briefing meetings 31 Μάιος 2006NewsMedicines CIS bio international withdraw their application for Scintimun 21 Μάιος 2006Press release Committee for medicinal products for veterinary use: Meeting of 16 to 18 May 2006 19 Μάιος 2006Press releaseVeterinary Committee for Orphan Medicinal Products: May 2006 meeting 17 Μάιος 2006Press releaseHumanRare diseases European Medicines Agency finds no signal for decreased effectiveness of HBVAXPRO and Procomvax 8 Μάιος 2006Press releaseMedicines 1 … 331 332 333 334 335 Page 335 of 384 336 337 338 339 … 384
Pharm Research Associates (UK) Ltd withdraws marketing authorisation application for Surfaxin 8 Ιούνιος 2006Press release
European Medicines Agency adopts a positive opinion for the use of Prozac in the treatment of children and adolescents suffering from depression 6 Ιούνιος 2006Press releaseHumanMedicinesPaediatrics
European Medicines Agency: Committee for Medicinal Products for Human Use 24-27 May 2006 2 Ιούνιος 2006Press releaseHumanMedicines
European Medicines Agency adopts first positive opinion for a medicinal product derived from transgenic biotechnology 2 Ιούνιος 2006Press releaseMedicines
European Union (European Commission and European Medicines Agency (EMEA)) and Food and Drug Administration (FDA) agree on guiding principles for joint FDA-EMEA voluntary genomic data submission briefing meetings 31 Μάιος 2006NewsMedicines
Committee for medicinal products for veterinary use: Meeting of 16 to 18 May 2006 19 Μάιος 2006Press releaseVeterinary
Committee for Orphan Medicinal Products: May 2006 meeting 17 Μάιος 2006Press releaseHumanRare diseases
European Medicines Agency finds no signal for decreased effectiveness of HBVAXPRO and Procomvax 8 Μάιος 2006Press releaseMedicines